CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
May 8th 2025
I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, laughter and a community of hope.
FDA Approves Third Herceptin Biosimilar
January 19th 2019The FDA has granted an approval to Ontruzant (SB3; trastuzumab -dttb), a Herceptin (trastuzumab) biosimilar, for the treatment of patients with HER2-overexpressing breast cancer or metastatic gastric or gastroesophageal junction adenocarcinoma.
Taming Cancer's Beasts One Treatment at a Time
January 2nd 2019Making peace with radiation can be a challenge, even if high doses of targeted radiation can silence cancer cells. It took me almost two weeks to tame the beast of fear. What have you done to trick yourself into handling difficult situations during cancer treatment?
FDA Approves Herceptin Biosimilar for Breast Cancer Treatment
December 15th 2018The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer.